Small Things Getting Big Importance

Size is becoming one of the key success factors today across many industries in this shrinking world. From cars to iPods, we see size and opportunity becoming more inversely proportional. Healthcare sector is no different in this trend. When it comes to instruments used in research/ diagnostics laboratories or even in point-of-care setting, reducing the foot print is given a top priority. Advancements in the development of micro total analysis systems (uTAS or mTAS) or lab-on-chip has slowly gained importance in various fields of which lifesciences is one of the major application areas.

PC/Mobile Computing in Lab Environments

As information technologies reshape the healthcare sector as a whole, hospitals have become more comfortable with accessing and sharing electronic information. Real-time access to information is very critical for an effective healthcare. It has been proven time and again that the most efficient means of information entry and access is offered by a combination of computing devices. It is acknowledged that wireless networks, which will aid point-of-care decision-making, information access and clinical data entry, are coming up steadily.

Pharmacogenomics and Personalized Medicine: Just a Technology Bubble or an Opportunity for Investment?

The pharmaceutical industry is facing some key challenges such as the increase in drug development cost, the decrease in the number of drugs being approved, and scrutiny from regulatory authorities to name a few.  Patients themselves are demanding more effective and safer drugs.

The European Biosimilars Market: Trends and Key Success Factors

Lead Discovery: Laying Foundations for Next-generation Drug Design

Current Trends in Genomic Applications within Europe

Genomics has emerged to be one of most productive and innovative sectors in life science markets. Modern research in genomics and molecular biology has helped the research community to develop life saving drugs and cures for complications such as obesity and Parkinson’s disease.

Systems Biology: An Integrative Approach to Drug Discovery

The way biological systems were perceived was changed almost five decades ago by Watson and Crick with their identification of the DNA double helix. Since then, enormous advances have been made in molecular biology in the understanding of biological processes such as disease, evolution, heredity and development on a molecular basis.

Insights Into Molecular Graphics

Emerging Trends in the European Proteomics Technology Markets

An Ode to Pharmacovigilance Solutions